CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Organon Pharma Indonesia Tbk PT is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Organon Pharma Indonesia Tbk PT
Gedung Wisma BNI 46
Lantai 27 Jln Jendral Sudirman Kav.1
Phone: +62 2157897000p:+62 2157897000 JAKARTA SELATAN, 12920  Indonesia Ticker: SCPISCPI
Business Summary
PT Organon Pharma Indonesia Tbk is an independent global healthcare company. It provides pharmaceutical products for women. Its activities comprise manufacturing and processing of medicines, health/food supplements, in finished form for humans, such as in the form of tablets, capsules, ointments, powders, solutions, parental solutions, and suspensions, hormonal contraceptive drugs, production of radiopharmaceutical industry, and the pharmaceutical industry biotechnology, and industrial medical dressings, bandages, and cosmetic cotton, and wholesale trade of laboratory equipment, pharmaceutical equipment and medical equipment for humans. Its segments include manufacturing and commercial. Its diverse portfolio of women's health, biosimilars, and established brands includes therapies and products for a range of conditions and diseases. Its products include ASMANEX HFA (mometasone furoate) inhalation aerosol, for oral inhalation use; Jada System; Ganirelix Acetate Injection, and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Commissioner JanVan Acker 7/1/2015 7/1/2015
President Director AshishPal 1/14/2015 1/14/2015
Director Ekert KaseyAnn 3/9/2017 3/9/2017
4 additional Officers and Directors records available in full report.

Business Names
Business Name
P.T. Schering-Plough Indonesia Tbk.
PT Schering Plough Indonesia Tbk
SCPI

General Information
Number of Employees: 187 (As of 9/30/2024)
Outstanding Shares: 3,600,000 (As of 9/30/2024)
Stock Exchange: JAK
Fax Number: +62 2131107009


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, February 1, 2025